Mechanistically, DEH exerts bidirectional regulation of NOD2: at lower concentrations, it suppresses NOD2 expression to potently inhibit colitis-associated inflammation, whereas at relatively higher concentrations, it activates NOD2 to induce autophagy in CRC cells, thereby achieving anticancer efficacy. This evidence concerns the gene NOD2 and colitis.